{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:45:26Z","timestamp":1777866326053,"version":"3.51.4"},"reference-count":54,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["chemistry-europe.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ChemBioChem"],"published-print":{"date-parts":[[2026,3,13]]},"abstract":"<jats:p>Hematologic malignancies, including leukemia, lymphoma, and multiple myeloma (MM), often present with nonspecific early symptoms that lead to misdiagnosis and delays in initiating treatment. These diseases pose substantial challenges to targeted therapy and prognostic monitoring. Compared with conventional antibodies and small\u2010molecule inhibitors, aptamers offer several distinct advantages, including high binding affinity, low immunogenicity, and facile chemical modification. These properties make aptamers particularly well\u2010suited to the clinical needs of hematologic oncology and highlight their promise for improving diagnosis and precision therapeutics. Since the first selection of aptamers targeting malignant hematologic cells two decades ago, the field has achieved remarkable progress. Aptamers have demonstrated considerable potential across key stages of cancer management, from biomarker discovery and tumor detection to targeted therapeutic intervention. This review presents a comprehensive overview of recent advances and provides an in\u2010depth discussion of future directions and remaining challenges.<\/jats:p>","DOI":"10.1002\/cbic.202500924","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T14:57:06Z","timestamp":1772981826000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research Advances in the Application of Aptamers for Hematologic Malignancies"],"prefix":"10.1002","volume":"27","author":[{"given":"Mingyan","family":"Wu","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Science Zhejiang University of Technology  Hangzhou China"},{"name":"Zhejiang Cancer Hospital The Key Laboratory of Zhejiang Province for Aptamers and Theranostics Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangru","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Cancer Hospital The Key Laboratory of Zhejiang Province for Aptamers and Theranostics Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Cancer Hospital The Key Laboratory of Zhejiang Province for Aptamers and Theranostics Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjun","family":"Chang","sequence":"additional","affiliation":[{"name":"Institute of Resources and Environment Henan Polytechnic University  Jiaozuo China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3145-1026","authenticated-orcid":false,"given":"Yunfen","family":"Hua","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science Zhejiang University of Technology  Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-053X","authenticated-orcid":false,"given":"Tao","family":"Bing","sequence":"additional","affiliation":[{"name":"Zhejiang Cancer Hospital The Key Laboratory of Zhejiang Province for Aptamers and Theranostics Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences  Hangzhou China"},{"name":"School of Molecular Medicine Hangzhou Institute for Advanced Study UCAS  Hangzhou China"},{"name":"University of Chinese Academy of Sciences  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01597-24"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","unstructured":"Y.Tan Y.Li andF.Tang \u201cNucleic Acid Aptamer: A Novel Potential Diagnostic and Therapeutic Tool for Leukemia \u201dOnco Targets and Therapy12(2019):10597\u201310613.","DOI":"10.2147\/OTT.S223946"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115646"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","unstructured":"J. E.Moore L.Munshi S. J.Mayo G.Armstrong andC. M.Dale \u201cSymptom Experiences of Critically\u2010Ill Hematologic malignancy Patients: A Scoping Review \u201dIntensive and Critical Care Nursing70(2022):103187.","DOI":"10.1016\/j.iccn.2021.103187"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7033"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202424687"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/bios12121142"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/bab.2244"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102142"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10020047"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602615103"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M115.051243"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/pr700894d"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101718"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404060121"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.07.004"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.4c03129"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.5c00118"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040715"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.07.099"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2025.111502"},{"issue":"7","key":"e_1_2_8_23_1","first-page":"2049","article-title":"Role of Minimal Residual Disease Assessment in Multiple Myeloma","volume":"109","author":"Szalat R.","year":"2024","journal-title":"Haematologica"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.34133\/research.0126"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac5045274"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2021.113367"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/bios12010023"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.31635\/ccschem.023.202302825"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03169-9"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5c01296"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040484"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.263"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5066"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.4590"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201900903"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.10.021"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124173"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02399-1"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093441"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0734-z"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9110635"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0228"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-493924"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174831"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22409"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2016.33"},{"issue":"3","key":"e_1_2_8_47_1","first-page":"561","article-title":"Screening and Structure Analysis of Nucleic Acid Aptamers Binding to Surface of CD33(+)\/CD34(+) Cells from Patients with Acute Myeloid Leukemia Subtype M2","volume":"19","author":"Zhang S. Q.","year":"2011","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202104341"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.972933"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00999-x"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2022_732"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201700513"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/10_2020_124"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.125"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01724-w"}],"container-title":["ChemBioChem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbic.202500924","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cbic.202500924","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbic.202500924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:28:12Z","timestamp":1777537692000},"score":1,"resource":{"primary":{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/10.1002\/cbic.202500924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3,13]]}},"alternative-id":["10.1002\/cbic.202500924"],"URL":"https:\/\/doi.org\/10.1002\/cbic.202500924","archive":["Portico"],"relation":{},"ISSN":["1439-4227","1439-7633"],"issn-type":[{"value":"1439-4227","type":"print"},{"value":"1439-7633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"2025-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e202500924"}}